323 related articles for article (PubMed ID: 36399162)
1. Prion assemblies: structural heterogeneity, mechanisms of formation, and role in species barrier.
Igel A; Fornara B; Rezaei H; Béringue V
Cell Tissue Res; 2023 Apr; 392(1):149-166. PubMed ID: 36399162
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process?
Igel-Egalon A; Bohl J; Moudjou M; Herzog L; Reine F; Rezaei H; Béringue V
Viruses; 2019 May; 11(5):. PubMed ID: 31083283
[TBL] [Abstract][Full Text] [Related]
3. Crossing Species Barriers Relies on Structurally Distinct Prion Assemblies and Their Complementation.
Igel-Egalon A; Laferrière F; Tixador P; Moudjou M; Herzog L; Reine F; Torres JM; Laude H; Rezaei H; Béringue V
Mol Neurobiol; 2020 Jun; 57(6):2572-2587. PubMed ID: 32239450
[TBL] [Abstract][Full Text] [Related]
4. Quaternary structure of pathological prion protein as a determining factor of strain-specific prion replication dynamics.
Laferrière F; Tixador P; Moudjou M; Chapuis J; Sibille P; Herzog L; Reine F; Jaumain E; Laude H; Rezaei H; Béringue V
PLoS Pathog; 2013; 9(10):e1003702. PubMed ID: 24130496
[TBL] [Abstract][Full Text] [Related]
5. Implications of prion adaptation and evolution paradigm for human neurodegenerative diseases.
Kabir ME; Safar JG
Prion; 2014; 8(1):111-6. PubMed ID: 24401672
[TBL] [Abstract][Full Text] [Related]
6. Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions.
Chapuis J; Moudjou M; Reine F; Herzog L; Jaumain E; Chapuis C; Quadrio I; Boulliat J; Perret-Liaudet A; Dron M; Laude H; Rezaei H; Béringue V
Acta Neuropathol Commun; 2016 Feb; 4():10. PubMed ID: 26847207
[TBL] [Abstract][Full Text] [Related]
7. Prion agent diversity and species barrier.
Béringue V; Vilotte JL; Laude H
Vet Res; 2008; 39(4):47. PubMed ID: 18519020
[TBL] [Abstract][Full Text] [Related]
8. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
9. Protease-sensitive prion species in neoplastic spleens of prion-infected mice with uncoupling of PrP(Sc) and prion infectivity.
Krasemann S; Neumann M; Szalay B; Stocking C; Glatzel M
J Gen Virol; 2013 Feb; 94(Pt 2):453-463. PubMed ID: 23136363
[TBL] [Abstract][Full Text] [Related]
10. Propagation of PrP
Chang SC; Hannaoui S; Arifin MI; Huang YH; Tang X; Wille H; Gilch S
Commun Biol; 2023 Nov; 6(1):1162. PubMed ID: 37964018
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
12. Cellular aspects of prion replication in vitro.
Grassmann A; Wolf H; Hofmann J; Graham J; Vorberg I
Viruses; 2013 Jan; 5(1):374-405. PubMed ID: 23340381
[TBL] [Abstract][Full Text] [Related]
13. The Smallest Infectious Substructure Encoding the Prion Strain Structural Determinant Revealed by Spontaneous Dissociation of Misfolded Prion Protein Assemblies.
Bohl J; Moudjou M; Herzog L; Reine F; Sailer F; Klute H; Halgand F; Rest GV; Boulard Y; Béringue V; Igel A; Rezaei H
J Mol Biol; 2023 Nov; 435(21):168280. PubMed ID: 37730082
[TBL] [Abstract][Full Text] [Related]
14. All the Same? The Secret Life of Prion Strains within Their Target Cells.
Vorberg IM
Viruses; 2019 Apr; 11(4):. PubMed ID: 30970585
[TBL] [Abstract][Full Text] [Related]
15. Glycoform-independent prion conversion by highly efficient, cell-based, protein misfolding cyclic amplification.
Moudjou M; Chapuis J; Mekrouti M; Reine F; Herzog L; Sibille P; Laude H; Vilette D; Andréoletti O; Rezaei H; Dron M; Béringue V
Sci Rep; 2016 Jul; 6():29116. PubMed ID: 27384922
[TBL] [Abstract][Full Text] [Related]
16. Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions.
Castilla J; Gonzalez-Romero D; Saá P; Morales R; De Castro J; Soto C
Cell; 2008 Sep; 134(5):757-68. PubMed ID: 18775309
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the histo-molecular pathology of human prion disease.
Baiardi S; Rossi M; Capellari S; Parchi P
Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685
[TBL] [Abstract][Full Text] [Related]
18. Understanding Intra-Species and Inter-Species Prion Conversion and Zoonotic Potential Using Protein Misfolding Cyclic Amplification.
Peden AH; Suleiman S; Barria MA
Front Aging Neurosci; 2021; 13():716452. PubMed ID: 34413769
[TBL] [Abstract][Full Text] [Related]
19. The first non-prion pathogen identified: neurotropic influenza virus.
Sakaguchi S; Hara H
Prion; 2022 Dec; 16(1):1-6. PubMed ID: 34978525
[TBL] [Abstract][Full Text] [Related]
20. Cofactors influence the biological properties of infectious recombinant prions.
Fernández-Borges N; Di Bari MA; Eraña H; Sánchez-Martín M; Pirisinu L; Parra B; Elezgarai SR; Vanni I; López-Moreno R; Vaccari G; Venegas V; Charco JM; Gil D; Harrathi C; D'Agostino C; Agrimi U; Mayoral T; Requena JR; Nonno R; Castilla J
Acta Neuropathol; 2018 Feb; 135(2):179-199. PubMed ID: 29094186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
